| Literature DB >> 34066290 |
Javier Montero1, Alicia Becerro1, Beatriz Pardal-Peláez1, Norberto Quispe-López1, Juan-Francisco Blanco1, Cristina Gómez-Polo1.
Abstract
Clinicians should be aware of the main methods and materials to face the challenge of bone shortage by manufacturing customized grafts, in order to repair defects. This study aims to carry out a bibliographic review of the existing methods to manufacture customized bone scaffolds through 3D technology and to identify their current situation based on the published papers. A literature search was carried out using "3D scaffold", "bone regeneration", "robocasting" and "3D printing" as descriptors. This search strategy was performed on PubMed (MEDLINE), Scopus and Cochrane Library, but also by hand search in relevant journals and throughout the selected papers. All the papers focusing on techniques for manufacturing customized bone scaffolds were reviewed. The 62 articles identified described 14 techniques (4 subtraction + 10 addition techniques). Scaffold fabrication techniques can be also be classified according to the time at which they are developed, into Conventional techniques and Solid Freeform Fabrication techniques. The conventional techniques are unable to control the architecture of the pore and the pore interconnection. However, current Solid Freeform Fabrication techniques allow individualizing and generating complex geometries of porosity. To conclude, currently SLA (Stereolithography), Robocasting and FDM (Fused deposition modeling) are promising options in customized bone regeneration.Entities:
Keywords: 3D printing; 3D scaffold; bone regeneration; tissue engineering
Year: 2021 PMID: 34066290 PMCID: PMC8152095 DOI: 10.3390/ma14102524
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1Flow chart of the search strategy.
Description of the 16 studies that, both in vivo and in vitro, evaluate the mechanical and regenerative properties of the different materials used to manufacture 3D scaffolds *.
| Author/Year | Material | Material and Methods | Fabrication Technique | Results |
|---|---|---|---|---|
| Eshraghi S. 2010 | Polymer. PCL | 3 scaffolds (1D, 2D, and 3D) with different geometries and orthogonal pores, each one more porous than the previous one. | SLS | The structures designed for load bearing locations were accurate with respect to the digital design, and compressive strength was significantly higher in the 1D scaffolds, and the same in the 2D and 3D scaffolds (10.0 ± 0.62 and 0.60 MPa respectively). |
| Lee SJ. 2019 | Polymer. PCl, PCLD (PCL with polydopamine) and PCLDB (BFP1: bone-forming peptide) | In vitro with human mesenchymal cells and in vivo with New Zealand rabbits. | FFF | Surface treatment with Dopamine and BFP1 considerably increases osteogenesis and angiogenesis. |
| Xu H. 2010 | Synthetic polymers. | Eight male Beagle dogs were used. | Lost-wax | The scaffolds were compared with the initial models and proved to be very accurate. The bioblocks demonstrated high biocompatibility when incubated in vitro with mesenchymal bone cells. |
| Gendviliene I. 2020 | Polymer and composite material. PLA and PLA/HA | Three groups of scaffolds ( | FFF | Pure PLA frames made with the Pharaoh XD20 printer showed greater accuracy compared to the Ultimaker Original 3D printer, although the highest accuracy was achieved with PLA/HA scaffolds. |
| Lin YH. 2017 | Composite material. CaSi + PCL | Human mesenchymal cells were used for the in vitro study. | DIW | By adding CaSi to the PCL, compressive strength (5.8 MPa) increased, as did hydrophilia and osteogenic differentiation and angiogenesis. |
| Roh HS. 2016 | Composite material. PCL + HA + MgO | The scaffolds were treated with oxygen and nitrogen plasma. They were analyzed in vitro with pre-osteoblastic cells. | FFF | The addition of HA and MgO facilitated the initial adhesion, proliferation and differentiation of the cells. The treatment with plasma increased hydrophilicity, enhancing the bioactivity of the scaffolds. |
| Pae HC. 2018 | Polymer and composite material. PCL + β-TCP. | Ten rabbits with 4 circular calvarial defects of 8 mm each: Control/PCL/PCL + β-TCP/PCL + β-TCP + membrane. | FFF | Compressive strength resistance was higher in PCL (46.7 ± 1.7 N/mm) than in PCL + β-TCP (35.7 ± 3.1 N/mm). PCL/β-TCP + M showed the highest total and new bone volume at 8 weeks and only bioblocks with β-TCP contained new bone (hydrophilicity and conductivity increased) |
| Kim BS | Bioceramics. HA and HA + PCL with BMP-2-loaded nanoparticles (NP) | Four rabbits were used with 3 calvarial defects of 6 mm: control/HA/HA + PCL + NP. | 3D printing | The PCL-NP coating was useful to incorporate BMP-2/NP to improve bone regeneration, and to improve compressive strength by the PCL (5.10 ± 0.49 MPa). |
| Miranda P. 2006 | Bioceramics. β-TCP | Structures with different inks, geometries, and nozzle diameters, sintered at different temperatures (1250 °C–1550 °C) depending on the composition of the powder. | DIW. Robocasting | Powders with reduced particle size and a low-specificity surface area were more suitable for manufacturing through robocasting. To avoid TCP transition (from beta to alpha): calcium deficient powders and sintering temperatures below 1125 °C. |
| Zhou Z. 2014 | Bioceramics. | The effects of particle size, the CaP/CaSO4 ratio and the type of CaP powder (HA/TCP) were measured. | 3D printing | Best result with a powder size of 30–110 microns and a higher proportion of CaP with respect to CaSO4 (25/75). HA performed better than b-TCP: good print accuracy and compressive strength for no-load defects (1.98 MPa). |
| Guda T. 2012 | Bioceramics. | Six cylindrical samples of each type of 8 mm in diameter and 16 in length | Lost-wax | Although the elastic module did resemble that of human bone, the compressive strength was much lower than that of the trabecular bone. It was also shown that the macropore size of the core does not influence the mechanical aspect. |
| Eqtesadi S. 2014 | Bioceramics. Bioactive glass 45S5 | Compared the mechanical properties of bioglass 45S5 obtained with robocasting against other techniques. | DIW. | Compressive strength = 2–13 MPa Robocasting is the best option for 45S5 glass structures with the necessary mechanical properties for their clinical application. |
| H. Shao. 2018 | Bioceramics. | Alveolar defects were created in the jaws of 32 rabbits. They were sacrificed at 8 and 16 weeks. A total of 64 samples were obtained. | DIW | In vitro, CSiMg10 scaffolds were placed in a liquid buffer and showed a slight dissolution, moderate weight loss (7%) and hardly any reduction in bending strength (31 MPa). In vivo, they revealed a significantly higher osteogenic capacity than the TCP, CSi and Bred scaffolds after 16 weeks. |
| ShaoH. 2017 | Bioceramics. | Structures of different thicknesses by printing in one or double layer and sintering in 1/2 steps. Twenty-four rabbits were used for the in vivo study. | FFF | CSiMg6 and two-step sintering showed the best compression and bending strength figures (104/18 MPa). Single layer structures had greater bone formation in the short term (4 weeks), and double layer in the long term (8–12 weeks). The CSi showed greater regeneration. In the CSiMg6, regeneration was also acceptable, with the advantage of high fracture resistance. |
| Lee. YK. 2008 | Bioceramics. | For the in vivo study, the following were used: Calvarial defects of 60 rats 12 intraosseous defects from 1 wall of 6 male Beagle dogs. | Lost-wax using polyurethane ester cross-linked sponges. | In vitro, the degree of dissolution and the calcification and mineralization were improved by Calcium phosphate glass. In vivo in rats and dogs, a significant improvement in bone and cement formations was observed with Calcium phosphate glass. |
| Tarafder S. 2013 | Bioceramics. | Twenty-four male rats in which 20 bioblocks of β-TCP pure (Control) and 20 doped with Sr-Mg (study) were placed. | 3D printing | The compressive strength of the study was higher than that of the control (12.01 ± 1.56 MPa and 10.95 ± 1.28 MPa respectively). At 12–16 weeks, the bone formed in the control was less mineralized. At 16 weeks, it was mineralized in both bioblocks. Biological performance in vivo was improved by the addition of SrO and MgO. |
* Visit the acronyms section at the end of the paper for the description of the material and/or technique mentioned in this table.
Description of the 22 main research works found after the bibliographic search that, both in vitro and in vivo, evaluate the regenerative efficacy and the mechanical properties of scaffolds obtained with different fabrication techniques *.
| Author/Year | Fabrication Technique | Study Design | Materials | Results |
|---|---|---|---|---|
| Cao H. 2010 | Solvent casting | In vivo: 40 rats with femur defects | Scaffolds made with HA and PGA-betaTCP at different % (1:1 and 1:3) were compared. | The PGA-betaTCP bioblock (1:3) obtained a higher density and new bone formation than the rest 90 days after surgery, as well as a reabsorption rate appropriate to the process. |
| Yang L. 2019 | TIPS | In vivo: Nine female New Zealand white rabbits were used, and two operations were performed on each. | PLGA and PLGA/bioglass scaffolds were compared. | Both implants had similar porosities (93.926% and 93.048% respectively) while the scaffold with bioglass showed a higher rate of cell adhesion. |
| Brie J. 2013 | SLA | In vivo: Eight bone implants in 8 patients | Hydroxyapatite | Three types of grafts were designed, two of which were solid and a third had macropores in the areas of attachment to the native bone. After healing, gaps were observed in the massifs on palpation, while the macropores formed a smooth interphase. |
| Staffa G. 2012 | SLA | In vivo: Sixty patients with large cranial defects. | Hydroxyapatite | None of the patients suffered rejection, spontaneous fracture, or mobilization of the graft and all reported good initial and long-term aesthetics. |
| Mangano F. 2013 | SLS | In vivo: Five patients with severe mandibular atrophy | Master alloy (Ti6Al4) | Blade-shaped dental implants were manufactured to rehabilitate atrophic maxillae. After 2 years of follow-up, all the implants were still in function and with good integration and good esthetic results. |
| Cox SC. 2015 | 3D printing | In vitro: They were printed on the | HA (50%) and PVOH (polyvinyl alcohol) | Variation in mechanical resistance (0.88 MPA in the |
| Inzana JA. 2014 | 3D printing | In vivo: Defects were created in the femurs of 12 female mice: Allografts ( 3D scaffold ( Empty ( | Pure calcium phosphate bioceramic, coated with collagen and embedded in collagen. | The mechanical resistance of all the pure calcium phospate was significantly lower than that of the allografts, although none reached the values of the intact femur (19.4 ± 5.6 N mm). In terms of bone formation, the scaffolds were osteoconductors but poorly osteoinductors; they did not completely cure the defect on their own. |
| Torres, J. 2011 | 3D printing | In vivo: Eight New Zealand rabbits in which a total of 16 bone blocks were placed in calvaria. | Monetite (calcium phosphate ceramic) | The surgical procedure was easy and fast. After 8 weeks, the 4 and 3 mm high blocks were fused to the bone surface and filled with 35% and 41% respectively of newly formed bone. |
| Lee JH. 2020 | FFF | In vitro: Human osteoblasts were used to determine compatibility and appropriate drug concentration. | PCL with rifampicin | Successful scaffolds were developed for the treatment of osteomyelitis by printing at 60 °C so as not to alter the properties of the drug. |
| Zheng P. 2019 | FFF | In vivo: Scaffolds were placed in 9 female New Zealand rabbits with femoral defects for osteochondral regeneration | PCL-HA coated with mesenchymal stem cells and chondrocytes | This PCL-HA scaffold promoted increased joint cartilage repair compared to the PCL-HA unseeded control scaffolds, thus concluding that the use of chondrocytes and mesenchymal cells stimulates cartilage regeneration. |
| Lethaus B. 2012 | FFF | In vivo: Manufacture of mandibles prior to resection in 20 patients to pre-form the reconstruction plates. | Not applicable | They demonstrated great accuracy and significantly facilitated the process. |
| Roohani-Esfahani SI. 2016 | DIW. (Robocasting) | In vitro: | Bioglass (Sr doped with Ca2ZnSi2O7(HT)) | Thanks to the optimization of the geometry, a compressive strength of 100–110 MPa and a high fatigue and flexural strength (30 MPa) were achieved: 150 times more than polymer and composite bioblocks and 5 times more than other made of bioceramics with similar porosity but different geometry. |
| Fu Q. 2011 | DIW. (Robocasting) | In vitro: Inks with 30% powder with low viscosity at 0° and high viscosity at 40 °C were used. An SBF was used to evaluate the properties. | Bioglass 6P53B | Compressive strength, with 60% porosity, of 136 ± 22 MPa, which remained above the values of the trabecular bone (77 MPa) after being immersed for 3 weeks in a simulated body fluid. |
| Hong SJ. 2009 | DIW | In vitro: Rat bone marrow stromal cells (rBMSC) were used. | PCL and PCL/HA | The HA-PCL scaffold with robotic dispensing has potential applications as a bioactive matrix. Despite showing limited cell adhesion, it proved to stimulate osteogenic differentiation. |
| Ma C. 2019 | DIW | In vitro: 3D and 2D scaffolds (membranes) were manufactured. All three groups of materials were cultured with fibroblasts in vitro. | PLLA, PLLA with tubular and spherical polypyrrole nanoparticles. | The nanoparticles increased the tensile strength (membranes from 100 to 250 MPa). Biocompatibility was satisfactory in all cases. Using these techniques, the 3D and 2D scaffolds were successful in optimizing the physiological microenvironment, which could be adapted to regenerate different tissues. |
| Franco J. 2010 | DIW. Robocasting | In vitro: The ink was created with 30–50% powder and Pluronic F-127 as hydrogel. | HA, b-TCP and HA/b-TCP with Pluronic F-127 solutions | A high pluronic content adds stability to the ink but, as a result, creates larger microporosities and less mechanical resistance. |
| Liu X. 2013 | DIW | In vivo: 30 male Sprague-Dawley rats in which calvarial defects were created in each parietal bone. | Bioglass 13-93. They were introduced into K2HPO4 to create a superficial layer of HA, or BMP-2 was added to the bioglass. | Both strategies both individually and in combination proved to be effective in improving bone regeneration of calvarial defects. |
| Abarrategi A. 2012 | DIW | In vivo: Rabbit muscle. Six rabbits. Rabbit bone (leg) Cinco rabbits. Sample collection after 3 weeks. Pig maxilla (palate). Eight pigs. Sample collection after 3 months. | Bioceramics (HA/betaTCP) with BMP-2 protein (study). | In muscle: Controls. Muscle growth (osteoconduction) Study. Bone growth (osteoinduction). In bone: Similar results between the study scaffolds and the BioOss were obtained; the scaffolds also presented the advantages of being customized and facilitating surgical insertion. |
| Tovar N. 2018 | DIW. (Robocasting). | In vivo: Fifteen New Zealand rabbits with radial diaphysis defects. They were analyzed at 8 ( | β-TCP | At 12 and 24 weeks, a large amount of bone was found which led to the regeneration of the marrow space. The amount of scaffold was much higher at 8 than at 12 and 24 weeks, between which there was not much difference. |
| Silva DN. 2008 | SLS and 3D printing | In vitro: Dry human skulls were used to measure and compare the accuracy of the techniques. | Gypsum powder and water were used as a binder. | The SLS and 3DP printing accuracy was acceptable; an error of 2.1% and 2.67% was obtained respectively when comparing the real skulls with those manufactured via these techniques from the CT. |
| Salmi M. 2013 | SLS, 3DP and PolyJet | In vitro: Dry human skulls were used to measure and compare the accuracy of the 3 techniques with a new measurement method. | Not applicable | Using the method used (based on positioning 6 balls on the 3D model, measuring the distance between them and determining their midpoint), they found considerably greater accuracy (0.18 ± 0.12%) with PolyJet technology as compared to SLS (0.79 ± 0.26%) and 3DP (0.67 ± 0.26). |
| Tagliaferri V. 2019 | FDM, SLS and MJF were compared. | In vitro: Six objects with different geometries were selected for analysis. | (Polyamide) Nylon 12 (in powder form for SLS and MJF and in filament form for FDM). | SLS and MJF have the advantage that several components can be manufactured at the same time. FDM technology has the greatest limitations due to the high time and cost, as well as the high environmental impact, which was minimal with the MJF technique. |
* Visit the acronyms section at the end of the paper for the description of the material and/or technique mentioned in this table.
Summary of the average porosity and macropore sizes reported in the studies described in Table 1 and Table 2.
| Author/Year | Material | Fabrication Technique | Porosity (%) | Macropore Size (μm) |
|---|---|---|---|---|
| Eshraghi S. 2010 [ | Polymer. PCL | SLS | 37–55 | 700 μm |
| Lee SJ. 2019 [ | Polymer. PCL, PCLD and PCLDB | FFF | 50 | 300 μm |
| Xu H. 2010 [ | Synthetic polymers. | Lost-wax | Not specified | Not specified |
| Gendviliene I. 2020 [ | Polymer and composite material. PLA and PLA/HA | FFF | 48 | 350 μm |
| Lin YH. 2017 [ | Composite material. CaSi + PCL | DIW | Not specified | 500 μm |
| Roh HS. 2016 [ | Composite material. PCL + HA + MgO | FFF (PED) | Not specified | 300 μm |
| Pae HC. 2018 [ | PCL y β-TCP. | FFF (PED) | 30 | 240–260 μm |
| Kim BS 2018 [ | Bioceramics. HA and HA + PCL | 3D printing | 65–67 | Not specified |
| Miranda P. 2006 [ | Bioceramics. Beta-TCP | DIW. Robocasting | 45 | 75 μm |
| Zhou Z. 2014 [ | Bioceramics. (CaSO4) | 3D printing | Not specified | 1–100 μm |
| Guda T. 2012 [ | Bioceramics. HA with cortical and trabecular layers. | Lost-wax | 60.1–71.7 | Outer layers 200–250 μm |
| Eqtesadi S. 2014 [ | Bioceramics. Bioactive glass 45S5 | DIW. | 60–80 | 287 × 820 μm |
| H. Shao. 2018 [ | Bioceramics. | DIW | TCP: 57.3 ± 4.4 | TCP: 302 μm × 261 μm |
| ShaoH. 2017 [ | Bioceramics. | FFF | CSi: SL 58.3 ± 1.9 DL 59.2 ± 2.3 SL 53.1 ± 1.4 | CSi: SL 305 μm × 132 μm DL 280 μm × 316 μm SL 277 μm × 130 μm |
| Lee. YK. 2008 [ | Bioceramics. | Lost-wax. | 80.7–90.3 | From 371.6 ± 12.8 μm to 703.2 ± 17.1 μm |
| Tarafder S. 2013 [ | Bioceramics. | 3D printing | 49.44 ± 4.64 | 350 μm |
| Cao H. 2010 [ | Biocomposites HA and PGA-β-TCP | Solvent casting | 88.4–93.6 | 483.3–504.2 μm |
| Yang L. 2019 [ | PLGA and PLGA/bioglass. | TIPS | 93–94 | 1–7 μm |
| Brie J. 2013 [ | Hydroxyapatite | SLA | 50–70 | 300–550 μm |
| Staffa G. 2012 [ | Hydroxyapatite | SLA | 70 | 150 μm |
| Mangano F. 2013 [ | Master alloy (Ti6Al4) | SLS | Not specified | Not specified |
| Cox SC. 2015 [ | HA (50%) and PVOH (polyvinyl alcohol) | 3D printing | 55 | 10–60 μm |
| Inzana JA. 2014 [ | Pure calcium phosphate bioceramic, coated with collagen. | 3D printing | Not specified | 50–70 μm |
| Torres, J. 2011 [ | Monetite (calcium phosphate ceramic) | 3D printing | 44 | Not specified |
| Lee JH. 2020 [ | PCL with rifampicin | FFF(MHDS) | Not specified | Not specified |
| Zheng P. 2019 [ | PCL-HA | FFF | Not specified | 200 μm |
| Lethaus B. 2012 [ | Not applicable | FFF | Not specified | Not specified |
| Roohani-Esfahani SI. 2016 [ | Bioglass (Sr doped with Ca2ZnSi2O7(HT)) | DIW. (Robocasting) | 50, 55, 60 and 70 | 450, 550, 900 and 1200 μm |
| Fu Q. 2011 [ | Bioglass 6P53B | DIW. (Robocasting) | 60 | 200 μm |
| Hong SJ. 2009 [ | PCL and PCL/HA | DIW | Not specified | 500 μm × 500 μm |
| Ma C. 2019 [ | PLLA, PLLA with tubular and spherical polypyrrole nanoparticles. | DIW/Solvent casting | Not specified | 100 μm |
| Franco J. 2010 [ | HA, b-TCP and HA/b-TCP with Pluronic F-127 solutions | DIW. Robocasting | 10–40 | 200 μm × 180 μm |
| Liu X. 2013 [ | Bioglass 13-93 with layers of HA. | DIW | 50 | 300 μm |
| Abarrategi A. 2012 [ | Bioceramics (HA/betaTCP) | DIW | Not specified | 225 μm × 400 μm |
| Tovar N. 2018 [ | β-TCP | DIW. Robocasting. | 58.6 ± 3.0 | 400 μm |
| Silva DN. 2008 [ | Gypsum powder. | SLS and 3D printing | Not specified | Not specified |
| Salmi M. 2013 [ | Not applicable | SLS, 3DP and PolyJet | Not specified | Not specified |
| Tagliaferri V. 2019 [ | Polyamide. | FDM, SLS and MJF. | Not specified | Not specified |
Figure 2Diagram classifying the main scaffold fabrication techniques according to the manufacturing method.
Figure 3Scientific support of each of the 14 techniques identified as potentially in force regarding the raw number of papers and the percentage of papers containing “bone scaffold”.